U.S. Stocks Back In The Red For ’18
Stocks dropped again on Tuesday as losses mounted for the world’s largest technology companies. Retailers also fell, and energy companies plunged with oil prices as the market sank back into the red for the year.
Oil prices tumbled another 6.6 percent as Wall Street reacted to rising oil supplies and concerns that global economic growth will slow down, a worry that’s intensified because of the trade tensions between the U.S. and China. U.S. crude has plunged 30 percent since early October.
Technology companies were hit after the Trump administration proposed new national security regulations that could limit exports of high-tech products in fields such as quantum computing, machine learning and artificial intelligence.
Retailers also skidded. Target’s profit disappointed investors as it spends more money to revamp its stores and its website, while Ross Stores, TJX and Kohl’s also fell on disappointing forecasts.
The S&P 500 index lost 48.84 points, or 1.8 percent, to 2,641.89. The Dow Jones Industrial Average sank 551.80 points, or 2.2 percent, to 24,465.64.
The tech-heavy Nasdaq composite lost 119.65 points, or 1.7 percent, to 6,908.82. The Russell 2000 index of smaller-company stocks shed 27.53 points, or 1.8 percent, to 1,469.01.
The Dow Jones Industrial Average has lost 3.7 percent in the last two days, and the S&P 500 is off 3.4 percent. The Nasdaq is off 4.7 percent. The S&P 500 index has fallen 9.9 percent from the record high it set exactly two months ago.
Investors are measuring a number of headwinds and increasingly playing it safe. The global economy is showing signs of weakening, with the United States, China and Europe all facing the rising threat of a slowdown, which can hurt demand for commodities such as oil and pose a threat to company profits. Trade tensions between the U.S. and China appear to be getting worse instead of improving, contributing to the sell-off in tech stocks and multinational industrial companies.
For much of this year, investors were hopeful the U.S. and China would easily resolve their differences on trade. That hope has faded in the last two months. Later this month, President Donald Trump and Chinese President Xi Jinping are expected to meet at a gathering of the Group of 20 major economies, and for investors, the newly proposed limits on tech exports were one more hint the leaders probably won’t reach a deal.
“A resolution doesn’t seem to be coming in the short term,” said Katie Nixon, the chief investment officer for Northern Trust Wealth Management. “A lot of the companies that are front and center (like) Alphabet, Apple, IBM ... could be significantly limited in the way they export their technology.”
Apple fell 4.8 percent to $176.98 and is down 23.7 percent from the peak it reached on Oct. 3, though it’s still up almost 5 percent this year. Microsoft lost 2.8 percent to $101.71 and IBM fell 2.6 percent to $117.20.
As the tech giants swoon, investors lately have turned to safer bets such as utilities, real estate companies and makers of household goods. They’ve also sought the safety of U.S. Treasuries.


Data Startup Geospiza Helps Cities Prepare for Disaster
Health Care Leadership Training
Advisor News
- How can more Americans achieve financial independence?
- Savers vs. spenders: How money management attitudes impact financial confidence
- Demonstrating the value of life insurance to Gen Z
- Poor money habits are a dealbreaker in a new relationship
- DC plan sponsors see opportunity in alternatives
More Advisor NewsAnnuity News
- CA judge certifies class action in teachers’ lawsuit over in-plan annuity fees
- Globe Life Inc. (NYSE: GL) Records 52-Week High Thursday Morning
- AM Best Managing Director Joins ‘Target Topics’ Podcast to Discuss State of Delegated Underwriting Authority Enterprises Market
- KBRA Assigns Rating to TruSpire Retirement Insurance Company
- Partial annuitization: How advisors can help clients balance income, growth
More Annuity NewsHealth/Employee Benefits News
- Walla Walla residents drop health insurance because of affordability under Trump
- New Life Science Study Findings Recently Were Reported by Researchers at Johns Hopkins University Bloomberg School of Public Health (Formulary-Related Insurance Denials of Single-Source Branded Drugs in the United States): Life Science
- Trademark Application for “MEMORIAL HERMANN HEALTH PLAN MEDICARE ADVANTAGE PLANS HEALTH PLAN COMMERCIAL GROUPS” Filed by Memorial Hermann Health System: Memorial Hermann Health System
- Harrison: Rising health insurance exchange costs bad news for working poor in MS
- 94% of Americans say Congress must act on health care costs
More Health/Employee Benefits NewsLife Insurance News
- How can more Americans achieve financial independence?
- AM Best Assigns Credit Ratings to MAAGAP Insurance Inc.
- Critical care riders: the living benefit more clients should understand
- Globe Life Inc. (NYSE: GL) Records 52-Week High Thursday Morning
- AM Best Upgrades Credit Ratings of Sagicor Financial Company Ltd. and Most of Its Subsidiaries
More Life Insurance News